Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial. Read more about Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial.
NRF2 activates macropinocytosis upon autophagy inhibition. Read more about NRF2 activates macropinocytosis upon autophagy inhibition.
Melanoma models for the next generation of therapies. Read more about Melanoma models for the next generation of therapies.
Can Genomic Sequencing Identify High-Risk Barrett's Esophagus Earlier Than Pathologists? Read more about Can Genomic Sequencing Identify High-Risk Barrett's Esophagus Earlier Than Pathologists?
The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America. Read more about The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America.
Advances and Challenges in Pediatric and Childhood Cancers. Read more about Advances and Challenges in Pediatric and Childhood Cancers.
Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells. Read more about Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells.
Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells. Read more about Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells.
